Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients

Sponsor
Universidade Federal do Rio de Janeiro (Other)
Overall Status
Completed
CT.gov ID
NCT01487291
Collaborator
Rio de Janeiro State Research Supporting Foundation (FAPERJ) (Other)
176
1
3.9
44.6

Study Details

Study Description

Brief Summary

At the Thrombophilia Clinic of the Hospital Federal dos Servidores do Estado do Rio de Janeiro there is a high prevalence of acute psychotic episodes, which allows the investigators to raise the suspicion that the thrombotic tendency or hypofibrinolysis play a role in the onset of the disease. It is striking that most of these patients, after some time on anticoagulants, no longer need to take psychiatric medication.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    If the thrombotic tendency plays a significant role in the etiology of psychosis, one would expect to find ischemic brain injuries in neuroimaging studies, but it does not happen. Therefore, if there is a correlation between thrombotic tendency-hypofibrinolysis and psychosis it is likely to occur at the biochemical level, such as in neuronal transmission.

    The investigators hypothesis is that mechanisms that inhibit tissue plasminogen activator (t-PA) and therefore promote hypofibrinolysis, are directly or indirectly involved in the genesis of psychosis, because t-PA participates in neuronal plasticity and low t-PA levels are related to dementia.

    Hypofibrinolysis due to t-PA inhibition can be seen in:
    • Insulin resistance, when the pancreas must produce large amounts of insulin and proinsulin by feedback. If pancreatic reserve is inadequate, the result is diabetes mellitus. If the response is adequate, proinsulin stimulates the production of PAI-1 (plasminogen activator inhibitor 1. PAI-1 inhibits the formation of plasmin, whose function is to dissolve fibrin which makes up the clot. Obesity, certain infections and inflammations potentiate insulin resistance.

    • Antiphospholipid antibody syndrome.

    • PAI-1 4G/5G or 4G/4G polymorphism.

    Some hypofibrinolysis indicators are:
    • severe dysmenorrhea, because strong uterine contractions are necessary to expel undissolved clots.

    • PCOS because plasmin is required to activate some metalloproteinases involved in ovary remodelling.

    • early pregnancy losses, as some metalloproteinases involved in placental angiogenesis are activated by plasmin,

    • preeclampsia and eclampsia, as metalloproteinases that dissolve elastic fibers of the placental vessels, to create a low flow resistance, are activated by plasmin. Vascular endothelial growth factor (VEGF), a protein that restricts glomerular porosity, is also activated by plasmin,

    • sudden death and heart attack before age 50 in first degree relatives.

    On physical exam, acanthosis, high body mass index, and in women, hirsutism and acne are indirect indicators of insulin resistance. Livedo suggest antiphospholipid antibody syndrome.

    This study intents to investigate the prevalence of hypofibrinolysis markers, such as PAI-1 4G/5G and 4G/4G, protein S deficiency, antiphospholipid antibodies and prothrombin G20210A, in psychotic patients.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    176 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients
    Study Start Date :
    Jan 1, 2013
    Actual Primary Completion Date :
    May 1, 2013
    Actual Study Completion Date :
    May 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    Psychotic patients

    Inpatients and outpatients followed at Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro, Brazil

    Outcome Measures

    Primary Outcome Measures

    1. Prevalence of hypofibrinolysis markers in psychotic patients [One year]

      The investigators' hypothesis is that a high prevalence of hypofibrinolysis markers will be probably found in psychotic patients.

    Secondary Outcome Measures

    1. Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Patients who Need Electroconvulsive Therapy [2013-2014]

      The investigators are assessing clinical and laboratory markers of plasminogen activator imbalance in psychiatric patients who require electroconvulsive therapy, specifically patients with major depressive disorders and schizophrenia.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Diagnosis of schizophrenia or schizoaffective disorder by the Semi-structured Interview MINI 5.0.
    Exclusion Criteria:
    • Inability to provide information.

    • Use of illicit drugs.

    • Infections such as cerebral toxoplasmosis in HIV seropositive or tertiary syphilis. Patients with "recurrent syphilis" will not be excluded, because false positive tests are common in antiphospholipid antibody syndrome.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Institudo de Psiquiatria da UFRJ Rio de Janeiro Brazil 22290-140

    Sponsors and Collaborators

    • Universidade Federal do Rio de Janeiro
    • Rio de Janeiro State Research Supporting Foundation (FAPERJ)

    Investigators

    • Study Chair: Antonio E Nardi, MD, PhD, Universidade Federal do Rio de Janeiro, Brazil

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Silvia Hoirisch Clapauch, MD, Responsible for the HFSE Thrombophilia Clinic, Universidade Federal do Rio de Janeiro
    ClinicalTrials.gov Identifier:
    NCT01487291
    Other Study ID Numbers:
    • UFRiodJaneiro
    First Posted:
    Dec 7, 2011
    Last Update Posted:
    Dec 16, 2014
    Last Verified:
    Dec 1, 2014
    Keywords provided by Silvia Hoirisch Clapauch, MD, Responsible for the HFSE Thrombophilia Clinic, Universidade Federal do Rio de Janeiro
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 16, 2014